Unbiased Quantitation of Alveolar Type II to Alveolar Type I Cell Transdifferentiation during Repair after Lung Injury in Mice

Autor: Jazalle McClendon, Rubin M. Tuder, Nicole L. Jansing, Peter M. Henson, Dallas M. Hyde, Rachel L. Zemans
Rok vydání: 2017
Předmět:
0301 basic medicine
Pulmonary and Respiratory Medicine
Pathology
medicine.medical_specialty
transdifferentiation
Cells
1.1 Normal biological development and functioning
Alveolar Epithelium
alveolar epithelium
Respiratory System
Clinical Biochemistry
Mice
Transgenic

Cardiorespiratory Medicine and Haematology
Biology
Lung injury
Stem cell marker
Transgenic
Epithelium
Green fluorescent protein
Mice
03 medical and health sciences
lung injury and repair
0302 clinical medicine
Underpinning research
In vivo
medicine
2.1 Biological and endogenous factors
Animals
Aetiology
Lung
Molecular Biology
Cells
Cultured

Cell Proliferation
Cultured
Alveolar type
Transdifferentiation
Lung Injury
Cell Biology
respiratory system
Cell biology
Pulmonary Alveoli
Major Technical Advances
030104 developmental biology
Alveolar Epithelial Cells
030220 oncology & carcinogenesis
Cell Transdifferentiation
Respiratory
Zdroj: American journal of respiratory cell and molecular biology, vol 57, iss 5
ISSN: 1535-4989
1044-1549
Popis: The alveolar epithelium consists of squamous alveolar type (AT) I and cuboidal ATII cells. ATI cells cover 95-98% of the alveolar surface, thereby playing a critical role in barrier integrity, and are extremely thin, thus permitting efficient gas exchange. During lung injury, ATI cells die, resulting in increased epithelial permeability. ATII cells re-epithelialize the alveolar surface via proliferation and transdifferentiation into ATI cells. Transdifferentiation is characterized by down-regulation of ATII cell markers, up-regulation of ATI cell markers, and cell spreading, resulting in a change in morphology from cuboidal to squamous, thus restoring normal alveolar architecture and function. The mechanisms underlying ATII to ATI cell transdifferentiation have not been well studied in vivo. A prerequisite for mechanistic investigation is a rigorous, unbiased method to quantitate this process. Here, we used SPCCreERT2;mTmG mice, in which ATII cells and their progeny express green fluorescent protein (GFP), and applied stereologic techniques to measure transdifferentiation during repair after injury induced by LPS. Transdifferentiation was quantitated as the percent of alveolar surface area covered by ATII-derived (GFP+) cells expressing ATI, but not ATII, cell markers. Using this methodology, the time course and magnitude of transdifferentiation during repair was determined. We found that ATI cell loss and epithelial permeability occurred by Day 4, and ATII to ATI cell transdifferentiation began by Day 7 and continued until Day 16. Notably, transdifferentiation and barrier restoration are temporally correlated. This methodology can be applied to investigate the molecular mechanisms underlying transdifferentiation, ultimately revealing novel therapeutic targets to accelerate repair after lung injury.
Databáze: OpenAIRE